U.S. Life Sciences Stock News

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

If you are wondering whether BridgeBio Pharma's share price still reflects good value or has run too far, it helps to step back and look at what the current valuation is really telling you. The stock last closed at US$75.25, with a 3.8% gain over the past week, a 1.3% decline over the past month, a 3.8% decline year to date, and a 112% return over the last year, plus a very large return over three years that is more than 7x. These sharp moves have been accompanied by regular clinical and...

Lufax Holding (NYSE:LU) has just posted its FY 2024 numbers, with third quarter revenue of C¥5,543.4 million and a basic EPS loss of C¥1.12 as the group continues to work through a period of negative earnings. The company has seen revenue move from C¥9,270.3 million and EPS of C¥1.68 in the second quarter of 2023 to C¥5,543.4 million and EPS of C¥1.12 loss in the third quarter of 2024, while trailing twelve month EPS has swung from a profit of C¥1.55 to a loss of C¥5.54. For investors, the...

Unsurprisingly, Diodes Incorporated's ( NASDAQ:DIOD ) stock price was strong on the back of its healthy earnings...

Investors were underwhelmed by the solid earnings posted by Amentum Holdings, Inc. ( NYSE:AMTM ) recently. We have done...

As February 2026 begins, the U.S. stock market has shown a strong start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, buoyed by positive economic developments such as a new trade deal with India and an uptick in manufacturing activity. In this environment of optimism and strategic shifts, small-cap stocks present intriguing opportunities for investors looking to capitalize on potential growth areas, particularly when insider actions suggest...

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 posting significant gains, reflecting renewed investor optimism amid economic developments such as trade agreements and manufacturing growth. In this environment of rising indices, identifying stocks that might be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

As February begins, U.S. stock indexes have surged, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing a record high. In this buoyant market environment, investors often look towards growth companies with strong insider ownership as these firms can offer potential stability and alignment of interests between management and shareholders.

As February 2026 begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing a record close. For investors looking beyond well-known stocks, penny stocks—typically representing smaller or newer companies—remain an intriguing area of exploration. Though often seen as a relic of past market trends, these stocks can offer unique growth opportunities when backed by solid financials and resilient balance sheets.

As the United States market kicks off February 2026 with a strong upward momentum, evidenced by significant gains in major indices like the Dow Jones Industrial Average and S&P 500, investors are keenly watching economic indicators that could impact small-cap stocks. Amidst these dynamic conditions, identifying promising opportunities often involves looking beyond headline-grabbing giants to uncover lesser-known stocks with potential for growth.

The market wasn't impressed with the soft earnings from Gilat Satellite Networks Ltd. ( NASDAQ:GILT ) recently. We did...

CNX Resources Corporation's ( NYSE:CNX ) robust earnings report didn't manage to move the market for its stock. Our...

BlackLine, Inc.'s ( NASDAQ:BL ) earnings announcement last week didn't impress shareholders. Despite the soft profit...

It's been a sad week for Melco Resorts & Entertainment Limited ( NASDAQ:MLCO ), who've watched their investment drop...

The Morning Bull - US Market Morning Update Tuesday, Feb, 17 2026 US stock futures are slightly weaker this morning, with E-mini S&P 500 contracts down about 0.25% and Nasdaq futures off around 0.6%, as investors weigh softer inflation against a cooling growth pulse. The US 10 year Treasury yield is sitting near a 2 and a half month low, which reflects hopes that the Federal Reserve may cut interest rates, something that could lower mortgage and borrowing costs. At the same time, recent...

As you might know, Moderna, Inc. ( NASDAQ:MRNA ) just kicked off its latest annual results with some very strong...

The most recent earnings report from Mattel, Inc. ( NASDAQ:MAT ) was disappointing for shareholders. However, our...

We wouldn't blame Cummins Inc. ( NYSE:CMI ) shareholders if they were a little worried about the fact that William...

The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...

SiTime (NasdaqGM:SITM) is reportedly in advanced talks to acquire Renesas Electronics' timing unit. The potential deal would be SiTime's largest acquisition to date and a major expansion of its core timing business. The transaction has not been confirmed, but reports suggest the deal size is substantial and discussions are well progressed. SiTime focuses on MEMS based precision timing solutions that are used across communications, data centers, automotive and industrial applications. The...

If you are trying to figure out whether Huntsman is a bargain or a value trap at around US$13.21, you will want to see how the current share price lines up with a few different valuation yardsticks. The stock has returned 1.2% over the last week and 10.9% over the last month, while year to date it is up 29.6% but still shows a 16.8% decline over 1 year, a 50.0% decline over 3 years and a 43.6% decline over 5 years. These mixed returns have put fresh attention on Huntsman, with recent...

In February 2026, Acadia Realty Trust reported its fourth-quarter and full-year 2025 results, showing higher sales and revenue but lower net income and earnings per share compared with 2024. Alongside earnings, the company highlighted nearly US$487.3 million of 2025 acquisitions and leadership changes that underscore its emphasis on financial reporting strength and urban street retail growth. Now we will examine how robust same-property NOI growth and acquisitive expansion may influence...

Brixmor Property Group Inc. recently reported fourth-quarter 2025 revenue of US$353.75 million and net income of US$137.13 million, alongside a full-year net income of US$386.23 million, a US$4.39 million real estate impairment charge, and a maintained quarterly dividend of US$0.3075 per share. At the same time, Brixmor issued 2026 net income guidance of US$299 million to US$312 million, signaling a more measured earnings outlook after a stronger 2025. We’ll now examine how Brixmor’s strong...

STERIS (STE) shares are back in focus after third quarter results topped revenue expectations, matched profit forecasts, and were accompanied by reaffirmed full year guidance, giving investors fresh information on the company’s operating momentum. See our latest analysis for STERIS. At a share price of $248.35, STERIS has a 1-day share price return of 1.69% and a softer 30-day share price return of a 7.56% decline. Its 1-year total shareholder return of 14.36% and 5-year total shareholder...